Major National Heart, Lung, and Blood Institute COPD Research Grant Funding FY 2020
Overview
Organization: National Heart, Lung, and Blood Institute
Start Date: 10/2019
End Date: Ongoing
Primary Goal: Goal 4: Increase and sustain research to better understand the prevention, pathogenesis, diagnosis, treatment, and management of COPD.
Secondary Goal(s):
Objective(s):
- Help expand, coordinate, and optimize COPD research efforts
- Improve methods for earliest detection and diagnosis and develop effective strategies for preventing the onset and progression of COPD
- Define and characterize the pathogenesis of COPD heterogeneity
- Develop personalized medicine for COPD based on the pathogenesis and clinical heterogeneity
- Promote research that can lead to strategies that help prevent the onset and progression of COPD and improve the quality of COPD care and management
Collaboration: We worked alone
Activity Type: Research
Activity Description
The National Heart, Lung, and Blood Institute (NHLBI) awards funding to research organizations to implement activities that further the goals and objectives of the COPD National Action Plan. For fiscal year 2020, NHLBI awarded large research grants to ten organizations to support their efforts in raising awareness to better understand the prevention, pathogenesis, diagnosis, treatment, and management of COPD. Organizations funded this cycle include: Brigham and Women’s Hospital; Columbia University Health Sciences; Koronis Biomedical Technologies Corporation; Sigray, Inc,; Sonavi Labs, Inc; University of Arizona; University of California, San Francisco; University of Chicago; University of Colorado Denver; and Weill Medical College of Cornell University.Funded research topics included:
• Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease;
• Development of a low dose clinical lung screening prototype for early detection of COPD and lung cancer using a novel x-ray source to enable Talbot-Lau interferometry;
• Early Origins of Chronic Lung Disease: Outcomes into the Fifth Decade of Life;
• Feelix @ Home: Testing and optimization of a smart stethoscope for home use to monitor changes in lung status of individuals with chronic conditions;
• Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study;
• Integrative Characterization on the function of COPD GWAS gene, HHIP;
• Multi-omic networks associated with COPD progression in TOPMed Cohorts;
• Portable Noninvasive Positive Airway Device for COPD Patient Therapy;
• The Virtual Mentored Implementation to Reduce REVISITS (Reducing Respiratory Emergent Visits using Implementation Science Interventions Tailored to Setting) Study;
• Understanding the Origins of Early COPD
Audience
General Audience: Researchers
Focused Audience: n/a
Program Reach: National
Type of Area: N/A
Setting: Workplace
Cost and Funding Sources
It was funded through NHLBI and funds to be allotted to grantees.Impact Analysis
The FY2020 cycle awarded grants to ten organizations. Results of their programs are in progress.Advice or Lessons Learned
N/ARelated Links
- Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease
- Development of a low dose clinical lung screening prototype for early detection of COPD and lung cancer using a novel x-ray source to enable Talbot-Lau interferometry
- Early Origins of Chronic Lung Disease: Outcomes into the Fifth Decade of Life
- Feelix @ Home: Testing and optimization of a smart stethoscope for home use to monitor changes in lung status of individuals with chronic conditions
- Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study
- Integrative Characterization on the function of COPD GWAS gene, HHIP
- Multi-omic networks associated with COPD progression in TOPMed Cohorts
- Portable Noninvasive Positive Airway Device for COPD Patient Therapy
- The Virtual Mentored Implementation to Reduce REVISITS (Reducing Respiratory Emergent Visits using Implementation Science Interventions Tailored to Setting) Study
- Understanding the Origins of Early COPD
Contact Information
National Heart, Lung, and Blood Institute
Program Analyst
Bethesda
Maryland